Opus Genetics
IRD • XNAS
Opus Genetics is a pharmaceutical preparations company trading on XNAS, led by CEO George Magrath, with a market cap of $391.3M.
Market Cap$391.3M
Employees14.0
CEOGeorge Magrath
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
IRD
Opus Genetics FAQ
Common questions about Opus Genetics
Opus Genetics is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $3.0M.
Opus Genetics has approximately 14 employees.